Related Experiment Video

Updated: Jun 12, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Functional and metabolic adaptation in uraemic cardiomyopathy

Katie Smith1, David Semple, Dunja Aksentijevic

  • 1Department of Biological Sciences and Hull York Medical School, University of Hull, Kingston-upon-Hull, United Kingdom.

Frontiers in Bioscience (Elite Edition)
|June 3, 2010
PubMed

Insights

Chronic kidney disease (CKD) causes heart failure through cardiac remodelling and reduced fatty acid oxidation in the uraemic heart. This study tracked kidney dysfunction alongside cardiac changes, revealing metabolic shifts that may worsen heart function.

Area of Science:

  • Nephrology
  • Cardiology
  • Metabolic Research

Background:

  • Cardiovascular complications are the primary cause of mortality in chronic kidney disease (CKD) patients.
  • Uraemia induces cardiac remodelling, notably left ventricular hypertrophy (LVH), a key predictor of heart failure.
  • The metabolic adaptations in the uraemic heart, specifically substrate oxidation shifts, remain poorly understood.

Purpose of the Study:

  • To investigate the progression of kidney dysfunction and its correlation with cardiac remodelling in experimental uraemia.
  • To assess metabolic changes, including substrate oxidation, in the uraemic heart.

Main Methods:

  • Experimental uraemia induced via subtotal nephrectomy in animal models.
  • Assessment of renal function, left ventricular hypertrophy (LVH), and in vitro cardiac function at 3, 6, and 12 weeks post-surgery.
  • Metabolic remodelling evaluated using 13C-NMR (Carbon-13 Nuclear Magnetic Resonance) spectroscopy.

Main Results:

  • Uraemic animals developed anaemia and progressive kidney dysfunction.
  • Significant left ventricular hypertrophy (LVH) was observed by 12 weeks in uraemic hearts.
  • Markedly reduced fatty acid oxidation was detected in the uraemic heart, despite preserved cardiac function at 12 weeks.

Conclusions:

  • Experimental uraemia leads to progressive kidney dysfunction and cardiac remodelling, including LVH.
  • A shift in myocardial substrate utilization from fatty acids to carbohydrates occurs in the uraemic heart.
  • This metabolic adaptation may contribute to the decline in cardiac function and eventual heart failure in CKD patients.

More Related Videos

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer11:26

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer

Published on: February 13, 2019

Related Concept Videos

Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Cellular Adaptation I: Introduction and Atrophy01:23

Cellular Adaptation I: Introduction and Atrophy

Cells can adapt to environmental changes to maintain function and avoid injury, a process called cellular adaptation. Adapted cells exist in a reversible intermediate state with changes in size, number, phenotype, metabolism, or function. These responses help cells meet altered physiological or pathological demands; for example, enlargement of breast and uterine tissues during pregnancy. Early adaptations may enhance function, but persistent stress eventually causes tissue damage.Types of...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...